A detailed history of Amalgamated Bank transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 955 shares of SERA stock, worth $6,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares
955
Previous 955 -0.0%
Holding current value
$6,494
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$5.6 - $11.69 $5,348 - $11,163
955 New
955 $6,000
Q2 2022

Aug 15, 2022

SELL
$1.2 - $3.62 $838 - $2,530
-699 Closed
0 $0
Q1 2022

Jun 30, 2022

BUY
$2.96 - $8.8 $2,069 - $6,151
699 New
699 $3,000

Others Institutions Holding SERA

About SERA PROGNOSTICS, INC.


  • Ticker SERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 29,596,900
  • Market Cap $201M
  • Description
  • Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...
More about SERA
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.